mRNA For Lung Cancer

Will it work?

  • Yes

    Votes: 5 33.3%
  • No

    Votes: 2 13.3%
  • Wait and see

    Votes: 8 53.3%

  • Total voters
    15
  • Poll closed .
Nearly $200B a year spent on treating cancer just in the U.S..
Big pharma doesn't want a cure for cancer.
There should be studies done on ivermectin, fenbendazole, mebendazole, intravenous vit. C, apricot seeds, certain mushrooms, etc....
Unfortunately big pharma would likely find a way to corrupt any study.
https://x.com/MakisMD
We are so desperate, there are actually scientists studying all those.

https://clinicaltrials.gov/study/NCT05318469#contacts-and-locations

Even I funded a research project on ivermectin to treat lung cancer because the researcher couldn't find funding.
 
Don’t even bother, someone this weekend with a degree in police shit was lecturing a oncologist and researcher from the Bay Area(San Francisco) why cancer is cured and Big Pharma is hiding it. I thought the guy was drunk, nope, full blown Alex Jones.
Agree. Peeps just like spouting off chit.

But this topic hits close to home for me. I just lost a family member Aug 7th to lung cancer. Of course he was a smoker. Still it was hard to see someone just retired at 60 yrs old lose the battle up in the Oncology Ward/6th floor of Columbia Medical in Manhattan.

Never got to the immunotherapy stage. God does it make me angry. Still I don't give a shit about Big Pharma or billionaire fat cats like, now Sen Rick Scott (who made his money with Columbia/HCA - not connected to Columbia University Medical I don't believe) and them making bucks or not because they are "hiding the cure for cancer". Nonsense.

Money in this country is made either way - finding a solution or preventing one from coming forward. Its like they say, if you want a secret to get out keep it in Washington, DC.

We humans think we are so smart. Pop a pill, but follow the gigo lifestyle. So dumb.
 
The onset of cancers is significantly influenced by various physiological and biological catalysts, such as genetic mutations, environmental factors, inflammation processes, and lifestyle variables. Each of these factors contributes to tumor initiation, development, and progression through intricate biological mechanisms.

Since most cancer treatments do not address the sources of genetic mutations and inflammation processes that lead to cancer, nor the environmental factors and lifestyle variables also responsible, the best they can do is try to combat the end effects.

Hence, cancer survival rates have generally improved over the years due to advancements in diagnosis and treatment. For example, the five-year relative survival rate has increased from 63.5% in 2000 to 71.3% in 2015, with further improvements noted in subsequent years, reaching 71.7% in 2016.

The upward trend in survival rates highlights the effectiveness of new medical technologies and therapies. Historical analyses indicated that patients diagnosed with cancer in 2015 had a survival rate of approximately 71.3%, which reflects improved treatment options compared to earlier periods. Moreover, data from the World Health Organization and other health organizations corroborate that significant enhancements in cancer diagnosis and treatment have positively impacted survival rates over time.

The advancements in cancer treatment have led to both better early detection and more effective therapies, contributing to reduced mortality rates. The mortality rate for cancer has consistently declined, with a 32% drop recorded from its peak in 1991 through to 2019. This reduction emphasizes the role of ongoing research, improved cancer care practices, and public health initiatives aimed at early detection.

In summary, cancer survival rates have seen a considerable increase over the past few decades, reflecting significant advancements in treatment, but until doctors thoroughly understand the intricate biological mechanisms that stimulate tumor initiation, development, and progression in the first place and know how to reverse them, good luck with finding ultimate cures for the disease.
Of course they will do all they can to increase survival rates. Dead people don't bring in $$$$.
 
Where there is action, there is hope. In the 1980s, HIV infection was almost a death sentence. The discovery of its genetic replication path enable development a drug cocktail making HIV infection less lethal. As for cancer, its from within so it's more challenging.
 
Agree. Peeps just like spouting off chit.

But this topic hits close to home for me. I just lost a family member Aug 7th to lung cancer. Of course he was a smoker. Still it was hard to see someone just retired at 60 yrs old lose the battle up in the Oncology Ward/6th floor of Columbia Medical in Manhattan.

Never got to the immunotherapy stage. God does it make me angry. Still I don't give a shit about Big Pharma or billionaire fat cats like, now Sen Rick Scott (who made his money with Columbia/HCA - not connected to Columbia University Medical I don't believe) and them making bucks or not because they are "hiding the cure for cancer". Nonsense.

Money in this country is made either way - finding a solution or preventing one from coming forward. Its like they say, if you want a secret to get out keep it in Washington, DC.

We humans think we are so smart. Pop a pill, but follow the gigo lifestyle. So dumb.
My deepest condolences to you.

Lung cancer life expectancy at diagnosis is < 12 months and 5 year survival is < 5%. Even for those that survive beyond 12 months they are usually in constant pain even with narcotics. I won't wish it on my worst enemy.
 
They are getting closer and closer to a cure. Right now, it's the discovery of treatments...not a cure.

Treatments are where the money is at right now. Much more than a Cure. As you stated...too much money to lose by finding a cure.

mRNA technique open the door to a lot of new research that's now being applied to Cancer Research. Researchers are doing things now to prevent Cancer from "adapting" that they weren't able to do before 10 years ago.

Regardless, the timeline is related to how fast the research is evolving thanks to Artificial Intelligence (AI). Without AI, we're stuck. Thus, the game changer is AI. Yet, even without a cure...treatments are getting much better resulting in people living longer after being diagnosed with Cancer.

wrbtrader
Sometimes I just write what I feel at any given moment in time. Don't ask me why or how, because I don't know anything about anything. I just type.

From Feb 2020:

But all that aside, I think one solution to the problem, and it may be forthcoming although I'd expect the AMA and the likes to scream bloody murder... I firmly believe that AI and one's complete medical history digitized from the day they were born will enable at least 40% of routine visits to be done in a kiosk type booth in the coming years. Everything from the dx, to drawing a drop of blood. Self serve "Doc-in-the-Boxes" if you will. No reason there shouldn't be. They would actually be better at flagging a serious problem early on. A thousand times better.

As it stands now, you have one brain diagnosing someone and perhaps sending them off to a specialist or perhaps missing something. With AI you will have the compilation of a million brains.

We have incredible technology now, but we are only at the tip of the iceberg. The family physician will probably go the way of the dinosaur in 50 years.
 
https://www.bbc.com/news/articles/ce806ndv8neo

Lung cancer caused ~20% of total cancer death, doubled the fatality of the next, colon cancer, so this is a big deal.

Why am I posting this on ET? Because it is a very tradable event: We can place + or - bets on Biontech, Moderna, PFE, MRK.... based on our opinion of mRNA and its efficacy (e.g. like COVID).

An option bet can be very profitable if you are correct.


.........

Stoney I wrote a few years back that I thought the real sector to be in would be biotech. I mean its such an obvious thing. Technology has exploded and these researchers are now armed with stuff that 15 years ago would have been unheard of. I really believe we are on the cusp of figuring out treatments/cures for many many things. The big killers like breast cancer and lung cancer.
There's so many small companies we've never heard of for the most part, but you can bet there are a handful that will create enormous wealth for those that got in early.
You'll find the right one for us Stoney, that's why I keep you around. ;)

.

EDIT:
And tbh, if anyone on ET will find one of those stocks first... as much as I mess with him, odds are it WILL be Stoney.
 
Last edited:
.........



EDIT:
And tbh, if anyone on ET will find one of those stocks first... as much as I mess with him, odds are it WILL be Stoney.
Biotechs are very tradable because most biotechs face binary events yet option pricing is not binary.

Most of the time the market gets it right but once in a while the market makes a mistake.

You are one of the good guys, take care sir.
 
My deepest condolences to you.

Lung cancer life expectancy at diagnosis is < 12 months and 5 year survival is < 5%. Even for those that survive beyond 12 months they are usually in constant pain even with narcotics. I won't wish it on my worst enemy.
Appreciate it.

But from initial diagnosis to final breath 6 weeks.
 
Back
Top